Substrate Binding Mechanism of HIV-1 Protease from Explicit-Solvent Atomistic Simulations
- 31 July 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (33) , 11811-11818
Abstract
The binding mechanism of a peptide substrate (Thr-Ile-Met-Met-Gln-Arg, cleavage site p2-NC of the viral polyprotein) to wild-type HIV-1 protease has been investigated by 1.6 μs biased all-atom molecular dynamics simulations in explicit water. The configuration space has been explored biasing seven reaction coordinates by the bias-exchange metadynamics technique. The structure of the Michaelis complex is obtained starting from the substrate outside the enzyme within a backbone rmsd of 0.9 Å. The calculated free energy of binding is −6 kcal/mol, and the kinetic constants for association and dissociation are 1.3 × 106 M−1 s−1 and 57 s−1, respectively, consistent with experiments. In the main binding pathway, the flaps of the protease do not open sizably. The substrate slides inside the enzyme cavity from the tight lateral channel. This may contrast with the natural polyprotein substrate which is expected to bind by opening the flaps. Thus, mutations might influence differently the binding kinetics of peptidomimetic ligands and of the natural substrate.Keywords
This publication has 58 references indexed in Scilit:
- Rapid and Accurate Prediction of Binding Free Energies for Saquinavir-Bound HIV-1 ProteasesJournal of the American Chemical Society, 2008
- A diverse view of protein dynamics from NMR studies of HIV‐1 protease flapsProteins: Structure, Function, and Bioinformatics, 2007
- Modeling Water Molecules in Protein−Ligand Docking Using GOLDJournal of Medicinal Chemistry, 2005
- Absolute free energies of binding of peptide analogs to the HIV‐1 protease from molecular dynamics simulationsJournal of Computational Chemistry, 2005
- Adaptive inhibitors of the HIV-1 proteaseProgress in Biophysics and Molecular Biology, 2005
- Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for functionStructure, 1999
- INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug DesignAnnual Review of Biophysics, 1998
- Estimates of relative binding free energies for HIV protease inhibitors using different levels of approximationsProtein Engineering, Design and Selection, 1998
- Inhibitor binding to the Phe53Trp mutant of HIV-1 protease promotes conformational changes detectable by spectrofluorometryBiochemistry, 1993
- Two-step binding mechanism for HIV protease inhibitorsBiochemistry, 1992